New study aims to reduce unnecessary liver specialist referrals
NCT ID NCT04435054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 1,000 people aged 40-80 with type 2 diabetes or obesity to find the best way to screen for advanced liver scarring (fibrosis) from fatty liver disease. Researchers tested combinations of blood tests and a special ultrasound (FibroScan) to see which approach most accurately identifies those who truly need a liver specialist. The goal is to reduce unnecessary referrals and make screening more efficient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nantes
Nantes, France
-
Centre Hospitalier Universitaire Dijon Bourgogne
Dijon, France
-
Hôpital Lyon Sud
Pierre-Bénite, France